RAPT Therapeutics shares surge 64% as GSK agrees $2.2B acquisition
Trump looms over Davos as CEOs, allies, and rivals weigh US policy shifts
Interview: $6,000 gold realistic as macro risks fuel rally: B2PRIME’s Mykuliak
Wall Street awaits payrolls data as rate hike risks return to focus
European lenders back Qivalis as race for digital euro alternatives grows
Hasbro stock jumps 7% as preliminary revenue tops estimates